Yaribeygi, H., Jamialahmadi, T., Moallem, S.A., Sahebkar, A
Psychedelics, including psilocybin and MDMA, have shown promise for treating addiction by altering reward behaviors, but there is lasting uncertainty about the suitability of this drug class after the FDA denied approval for Lykos MDMA drug for PTSD in 2024
Research suggests it may improve cognitive function, reduce depressive symptoms, and even enhance sleep quality by decreasing oxidative stress
Prabhakar Life.2025
From an endolymphatic surface view of the organ of Corti, each stack contained ribbon synapses from six to nine IHCs